TBARs and non-enzymatic antioxidant parameters in Tunisian bipolar I patients

Immuno-Analyse et Biologie Specialisee

Volumn 27, Issue 6, 2012, Pages 315-324

  Ezzaher, A ^a   Haj Mouhamed, D ^a   Mechri, A ^a   Neffati, F ^a   Douki, W ^a   Gaha, L ^a   Najjar, M F ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Bipolar I disorder; Mood stabilizers; Oxidative stress biomarkers

Indexed keywords

ALBUMIN; BILIRUBIN; MOOD STABILIZER; THIOBARBITURIC ACID REACTIVE SUBSTANCE; URIC ACID;

ADULT; ALBUMIN BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BIPOLAR I DISORDER; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SHORT SURVEY; SMOKING; TUNISIA; URIC ACID BLOOD LEVEL;

EID: 84870756733     PISSN: 09232532     EISSN: 18781365     Source Type: Journal    
DOI: 10.1016/j.immbio.2012.06.003     Document Type: Short Survey

References (28)

1. Ezzaher E, Haj MD, Mechri A, Neffati F, Rejeb J, Omezzine A, et al. Association between bipolar I disorder and the L55M and Q192R polymorphisms of the paraoxonase 1 (PON1) gene. J Affect Disord 2009 [Epub ahead of print].
2. Andrezza A.C., KauerSant'Anna M., Frey B.N., Bond D.J., Kapczinski F., Young T.L., et al. Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord 2012, 139:12-17.
3. Ng F., Berk M., Dean O., Bush A.I. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 2008, 11:851-876.
4. Andrezza A.C., Cassini C., Rosa A.R., Leite M.C., de Almeida L.M., Nardin P., et al. Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res 2007, 41:523-529.
5. Ranjekar P.K., Hinge A., Hegde M.V., Ghate M., Kale A., Sitasawad S., et al. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatr Res 2003, 121:109-122.
6. Kuloglu M., Ustundag B., Atmaca M., Canatan H., Tezcan A.E., Cinkilinc N. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct 2002, 20:171-175.
7. Hovatta I. Juhila J., Donner J. Oxidative stress in anxiety and comorbid disorders. Neurosci Res 2010, 68:261-275.
8. Salvadore G., Viale C.I., Luckenbaugh D.A., Zanatto V., Portela L.V., Souza D.O., et al. Increased uric acid levels in drug-naive subjects with bipolar disorder during a first manic episode. Prog Neuropsychopharmacol Biol Psychiatr 2010, 34:819-821.
9. Yumru M., Savas H.A., Kalenderoglu A., Bulut M., Celik H., Erel O. Oxidative imbalance in bipolar disorder subtypes: a comparative study. Prog Neuropsychopharmacol Biol Psychiatr 2009, 33:1070-1074.
10. Kunz M., Gama C.S., Andrezza A.C., Salvador M., Ceresér K.M., Gomes F.A., et al. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatr 2008, 32:1677-1681.
11. De Brardis D., Conti C.M., Campanella D., Carano A., Di Giuseppe B., Valchera A., et al. Evaluation of plasma antioxidant levels during different phases of illness in adult patients with bipolar disorder. J Biol Regul Homeost Agents 2008, 22:195-200.
12. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2004, American Psychiatric Association, Washington, DC, USA. 4th ed.
13. World Health Organization. Obesity: preventing and managing the global epidemic (publication WHO/NUT/NCD/98.1). Geneva, Switzerland; 1997.
14. Ozcan M.E., Gulec M., Ozerol E., Polat R., Akyol O. Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol 2004, 19:89-95.
15. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39:44-84.
16. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J Neurochem 2006, 97:1634-1658.
17. Steckert A.V., Valvassori S.S., Moretti M., Dal-Pizzol F., Quevedo J. Role of oxidative stress in the pathophysiology of bipolar disorder. Neurochem Res 2010, 35:1295-1301.
18. Torres I.J., Boudreau V.G., Yatham L.N. Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand Suppl 2007, 434:17-26.
19. Machado-Vieira R., Lara D.R., Souza D.O., Kapczinski F. Therapeutic efficacy of allopurinol in mania associated with hyperuricemia. J Clin Psychopharmacol 2001, 21:621-622.
20. Machado-Vieira R., Lara D.R., Souza D.O., Kapczinski F. Purinergic dysfunction in mania: an integrative model. Med Hypotheses 2002, 58:297-304.
21. Burnstock G. Purinergicsignalling and disorders of the central nervous system. Nat Rev Drug Discov 2008, 7:575-590.
22. Lorenzi T.M., Borba D.L., Dutra G., Lara D.R. Association of serum uric acid levels with emotional and affective temperaments. J Affect Disord 2010, 121:161-164.
23. Yamaguchi T., Shioji I., Sugimoto A., Komoda Y., Nakajima H. Epitope of 24G7 anti-bilirubin monoclonal antibody. Biochim Biophys Acta 1996, 1298:110-114.
24. Miyaoka T., Yasukawa R., Yasuda H., Shimizu M., Mizuno S., Sukegawa T., et al. Urinary excretion of biopyrrins, oxidative metabolites of bilirubin, increases in patients with psychiatric disorders. Eur Neuropsychopharmacol 2005, 15:249-252.
25. Yasukawa R., Miyaoka T., Yasuda H., Hayashida M., Inagaki T., Horiguch J. Increased urinary excretion of biopyrrins, oxidative metabolites of bilirubin, in patients with schizophrenia. Psychiatr Res 2007, 153:203-207.
26. Hamon I., Valdes V., Franck P., Buchweiller M.C., Fresson J., Hascoeta J.M. Différences liées au sexe dans le métabolisme du glutathion (GSH) du grand prématuré. Arch Pediatr 2001, 18:247-252.
27. Kregel K.C., Zhang H.J. An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol 2007, 292:R18-R36.
28. Keaney J.F., Larson M.G., Vasan R.S., Wilson P.W.F., Lipinska I., Corey D., et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham study. Arterioscler Thromb Vasc Biol 2003, 23:434-439.